To address Africa’s chronic disease burden, mPharma wants to solve the cost of medications
MPharma disrupts the African prescription drug supply industry by stocking pharmacy shelves with no payment required up front. It uses the collective power of its network of pharmacies to negotiate lower prices with the best manufacturers, and it harnesses technology to eliminate the inefficiencies and price fluctuations that prevent prescription drugs reaching sick people.
-
Industry
-
Milestones
- Lux investment: 2022
-
Founders
- Gregory Rockson
- Daniel Shoukimas
- James Finucane
LUX Partners
-
Latest Tweets
- Our intervention in the fight against the pandemic helped various governments overcome the challenges of government… https://t.co/o07UKZl2ww
- Over the past eight years, we have served to ensure drug availability and accessibility within the markets we opera… https://t.co/9YE76xhCBG
- We launched our impact report on the 28th of April and among the guest speakers was the former Minister of Health,… https://t.co/PDER3oub5f